NAP1L1 and renal carcinoma: In previous studies, NAP1L1 expression was reported to be upregulated in several cancers such as renal cancer cell [19], pancreatic neuroendocrine neoplasm [12] and colon cancer [20], but its prognostic value has not yet been reported.